What complications can arise from Morganella morganii infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Morganella morganii Complications

Morganella morganii infections can lead to severe, life-threatening complications including sepsis/bacteremia (with 42% in-hospital mortality), necrotizing soft tissue infections, pneumonia in immunocompromised hosts, endophthalmitis with vision loss, osteomyelitis with septic arthritis, and urinary tract infections that may progress to systemic disease.

Primary Complications by System

Bloodstream Infections and Sepsis

The most critical complication is bacteremia/sepsis, which carries an exceptionally high mortality rate. Patients with M. morganii sepsis demonstrate 42% in-hospital mortality compared to 25% for E. coli sepsis 1. Key risk factors for death include:

  • Debilitative state
  • Charlson Comorbidity Index >4
  • Septic shock
  • Clinical syndrome other than UTI
  • Longer hospitalization (25 days versus 14 days for E. coli) 1

A critical pitfall: only 62% of M. morganii sepsis patients receive appropriate empirical antibiotics versus 83% for E. coli, contributing to worse outcomes 1.

Soft Tissue Complications

Necrotizing soft tissue infections represent a devastating complication with rapid progression and high mortality 2. These infections:

  • Occur more frequently with M. morganii than E. coli (30% versus 3.2%) 1
  • Require immediate surgical debridement
  • Can be fatal despite appropriate intervention (as demonstrated in the 2025 case where the patient died 14 days post-hospitalization despite surgery and targeted antibiotics) 2
  • May occur in immunocompromised patients with underlying conditions like microscopic polyangiitis 2

Respiratory Complications

Pneumonia from M. morganii occurs primarily in functionally neutropenic or immunocompromised patients 3. This pathogen should be considered in pneumonia cases where standard pathogens are not identified, particularly in patients with hematologic malignancies 3. The infection may present without characteristic radiographic consolidations, showing only atelectasis and trace effusions 3.

Ophthalmologic Complications

Endophthalmitis caused by M. morganii results in severe visual sequelae and can progress to bacteremia 4. This represents a medical emergency requiring:

  • Immediate identification through conjunctival cultures
  • Aggressive antimicrobial therapy based on susceptibility testing
  • Recognition that the organism may be resistant to cephalosporins and carbapenems while producing extended-spectrum beta-lactamases 4

Osteoarticular Complications

Osteomyelitis with secondary septic arthritis has been documented 5. These infections demonstrate slow-paced progression with occasional attacks and remissions, making diagnosis challenging 5. The mortality rate for osteoarticular M. morganii infections is notably high 5.

Urinary Tract Complications

While UTIs are the most common presentation, complications include:

  • Progression to bacteremia, particularly in children with urological abnormalities 6, 7
  • Higher risk in patients with neurogenic bladder, myelomeningocele, or catheter use 7
  • Potential for kidney damage if untreated 7

High-Risk Populations

Immunocompromised patients face the greatest complication risk, including those with:

  • Hematologic malignancies (especially acute myeloid leukemia with monocytic differentiation) 3
  • Functional neutropenia 3
  • Chronic kidney disease 2
  • Autoimmune conditions requiring immunosuppression 2
  • Urological abnormalities or catheter dependence 7

Critical Clinical Pitfalls

  1. Inappropriate empirical therapy: The intrinsic resistance pattern of M. morganii (resistant to penicillins, first-/second-generation cephalosporins, often amoxicillin-clavulanate and nitrofurantoin) leads to treatment failures 6, 7

  2. Delayed recognition: M. morganii should be included in differential diagnosis when standard pathogens are not identified, even without characteristic imaging findings 3

  3. Underestimation of severity: Higher Charlson Comorbidity Index (4.3 versus 3.4 for E. coli) and more complicated presentations require aggressive management 1

  4. Resistance patterns: Isolates may produce extended-spectrum beta-lactamases and demonstrate carbapenem resistance, necessitating susceptibility-guided therapy 4

References

1
Research

Clinical manifestations, risk factors and prognosis of patients with Morganella morganii sepsis.

Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2019

Related Questions

What is the appropriate management for a 75-year-old female with a Morganella morganii urinary tract infection that is resistant to all antibiotics except meropenem?
How should I manage a urine culture that isolates Morganella morganii subsp. morganii at >100,000 CFU/mL (significant) and a second Gram‑negative bacillus at <10,000 CFU/mL (likely contaminant)?
What is the recommended therapy for a Morganella morganii infection in a patient allergic to penicillin?
Does Augmentin (amoxicillin‑clavulanate) provide coverage against Morganella morganii?
Is Morganella species a common cause of urinary tract infection?
In a 64-year-old woman with Lambert-Eaton myasthenic syndrome who was recently started on azathioprine (Imuran) and now has a progressively worsening painful swollen right knee that forces her to drag the leg when getting out of a car, what differential diagnoses should be considered and what laboratory studies are indicated?
In a patient refusing benzodiazepines during alcohol withdrawal detoxification, is it appropriate to add levetiracetam (Keppra) or gabapentin?
A teenager previously treated for Cyclospora with trimethoprim‑sulfamethoxazole (TMP‑SMX) now has recurrent diarrhea; what evaluation and management steps are recommended?
What is the maximum recommended daily dose of quetiapine (Seroquel) for bipolar disorder in a 62‑year‑old male currently taking olanzapine 20 mg and refusing insulin for hyperglycemia?
What lifestyle and therapeutic interventions can increase basal metabolic rate?
Can Otezla (apremilast) cause renal impairment or flank pain?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.